Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis by Additional Mepolizumab

<div>(a) Sinus CT before the administration of mepolizumab. CT shows fluid and mucosal thickening in the maxillary sinuses on both sides, predominantly on the right. (b) Sinus CT in 6 months after the administration of mepolizumab. CT shows a decrease in fluid and mucosal thickening of the maxillary sinuses on both sides.</div>

Case Reports in Rheumatology

fig1

Figure 1

Figure 1: Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis by Additional Mepolizumab 

Figure 1 | Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis by Additional Mepolizumab 